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Summary 
The viral regulatory gene, nef,  is unique to the human immunodeficiency viruses (HIV) and 
their related primate lentiviruses. Expression of the nefgene has been shown to be essential to 
the maintenance of high levels of virus replication and the development of pathogenesis in the 
animal model of simian immunodeficiency  virus (SIV) infection. In contrast to this in vivo model, 
the use of standard T cell culture systems to study neffunction in vitro has produced a spectrum 
of contradictory results, and has failed to demonstrate a significant positive influence of nefon 
viral life cycle. We have developed a cell model to study regulation of HIV-1 replication that 
we believe reflects more accurately virus-cell interactions as they occur in vivo. Our experimental 
system used acute virus infection of purified, quiescent CD4 lymphocytes and subsequent induction 
of viral replication through T  cell activation. With this cell model, NL4-3 virus clones with 
open and mutated nef reading frames were compared for replication competence. The clones 
with nefmutations showed reproducible and significant reductions in both rates of growth and 
maximal titers achieved. The degree of reduced replication was dependent on initial virus inoculum 
and the timing of T  cell activation. The influence of nef was highly significant for induction 
of virus replication from a latent state within resting CD4 cells. Its effect was less apparent for 
virus infection of fully proliferating CD4 cells. This study demonstrates that nefconfers a positive 
growth advantage to HIV-1 that becomes readily discernable in the primary cell setting of virus 
induction through T cell activation.  The experimental cell model, which we describe here, provides 
not only a means to study neffunction in vitro, but also provides important clues to the function 
of nef in HIV infection in vivo. 
T 
he viral regulatory gene, nef, is unique to HIV types 
1 and 2, and the related primate lentiviruses. Although 
its mechanism of action is not understood, nefgene function 
has been shown to be essential for the maintenance of high 
levels of virus replication and the development of disease patho- 
genesis in the in vivo model of simian immunodeficiency  virus 
(SIVmac)  1 infection of the macaque monkey (1). In HIV-1 
infection of humans, there appears  to be selective pressure 
for retention of highly conserved sequences of nefand an open 
reading flame (ORF)  (2,  3).  In contrast to these data im- 
plying an important role for nefduring in vivo infection, the 
use of standard cell culture systems to study nef function in 
vitro has produced a wide spectrum of contradictory results. 
Several studies have described modest to severe repression of 
1 Abbreviations used in thistmper: OR.F, open reading  flame; SIVmac,  simian 
immunodeficiency  virus; TCIDs0, 50% tissue culture infectious dose. 
LTR driven transcription by nef expression (4-7),  whereas 
other reports have demonstrated a lack of effect on rates of 
viral transcription or replication (8, 9). More recent studies 
have shown small to moderate positive effects of nefon HIV 
replication in PBMC cultures that were selective for certain 
aUelic sequences of nef and that were revealed in a specific 
low growth, viral genetic background (10, 11). The only point 
of consensus drawn from in vitro studies has been the finding 
that nef gene function is not required for HIV replication 
in cell culture (4,  5,  12,  13). 
Because productive replication of HIV-1 is dependent on 
T  cell activation and proliferation (14,  15), all of the above 
mentioned in vitro experimental systems have utilized CD4 
T cell lines of malignant phenotype or fully proliferating cul- 
tures of PBL to study components of virus infection and repli- 
cation. The vast majority of T  lymphocytes in the natural 
in vivo setting, however, are quiescent nondividing cells with 
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clonal expansion at any given time (16). Study of HIV infec- 
tion and control of virus replication in continuous cultures 
of proliferating CD4 cells may not represent the most rele- 
vant in vitro model. In fact, data from several different studies 
indicate that HIV found in CD4 lymphocytes of the periph- 
eral circulation and lymph nodes is maintained predominantly 
in a nonproductive viral state either as unintegrated proviral 
DNA (17) or in stages of  blocked R.NA transcription (18-20). 
In addition, recent work to elucidate a function for the HIV-1 
nefgene indicates that nefhas  the ability to perturb normal 
T  cell functions. Several research groups have reported that 
expression  of NEF protein in T cells causes a wide range of 
disturbance including downregulation of CD4 cell membrane 
expression (21, 22),  suppression  of IL-2 gene transcription 
(23), and inhibition of nuclear factor (NF)-KB induction (24). 
All of these affected events  occur in the process  of normal 
T cell stimulation. Potential interactions with regulatory com- 
ponents of HIV replication might be lost or minimized in 
a  cellular  setting  of abnormal,  maximal,  and  continued 
proliferation. 
In an attempt to reflect more accurately virus-cell interac- 
tions as they occur in vivo, we have developed  a cell model 
to study the regulation of HIV-1 replication using acute virus 
infection of purified, quiescent primary CD4 lymphocytes 
to establish  a nonproductive infection, and subsequent in- 
duction of productive viral replication through mitogen ac- 
tivation of the T cell proliferation cascade. To determine the 
influence of nefon HIV-1 replication, we have constructed 
isogenic nef-mutated clones from the NL4-3 parental clone 
which contains OKFs for all the known genes of HIV-1, 
including nef (25).  Using this experimental model, we re- 
port a significant positive effect of nefon HIV-1 replication 
that is demonstrated by 10-500-fold differences in replica- 
tion, and that is apparent even with high viral inoculum. 
Our results show that nefhas a major influence on the ability 
of HIV-1 to achieve maximal levels of replication in primary 
CD4 cells during cellular induction from a nonproductive 
viral state to a fully productive replication cycle. 
Materials and Methods 
Construction of  Plasmid Clones with nef  Gene Mutations.  The HIV-1 
plasmid clone pNL4-3, which contains ORFs for all the major viral 
genes (25), was used to derive nefgene mutants (Fig. 1). To con- 
struct the deletion mutation, Anef, the circular plasmid pNL4-3 
(AIDS Research and Reference Reagent Program, National Insti- 
tutes of Health, Bethesda, MD) which contains eight BgllI cleavage 
sites was partially digested with diluted BgllI such that 10-20% 
of the DNA was converted to full-length linear form. This DNA 
was completely digested at the unique EspI site and then treated 
with the large fragment of Escherichia coli DNA polymerase I and 
the four deoxynucleoside  triphosphates. The resulting blunt-ended 
DNA was diluted to 100 ng/100/xl and treated with T4 DNA 
ligase to circularize the plasmid fragments. To linearize those DNA 
molecules  which retained  nefgene sequences  between EspI and BgllI, 
the circular DNA was digested with XhoI and used to transform 
E.  coli DH5  (GIBCO  BRL, Gaithersburg, MD).  The desired 
plasmid DNA, in which the XhoI site was missing and the EspI 
site was fused to the BgllI site at nucleotide position 9041, was 
identified by restriction enzyme mapping. A second nef mutant, 
nef/DS, was constructed using a PCR method (26) to introduce 
two point mutations resulting in stop signals at codons 37 and 
61 in the NL4-3 nefreading frame. Three PCK amplifications  were 
performed. Circular pNL4-3 was linearized  with SalI digestion and 
used as template in the first two reactions. In the first amplification, 
the 5' oligonucleotide primer contained sequence bases 8441-8466 
(primer-I,  GACAGATCCATTCGATTAGTGAACGG),  and  the 
3' primer sequence directed a G to A point mutation at position 
8825  (primer-3, CATTCTTTCCCTTACAGCAGG_TCATCC- 
AAT). Each primer (0.25 #g) was used in a DNA PCR of 100 
#1 containing 1.25 mM of each dNTP, 10 mM Tris-HC1 (pH 8.3), 
50 mM KC1, 2.5 mM MgC12, and 2.5 U Taq polymerase (Perkin 
Elmer Cetus, Los Angeles, CA). PCR was performed for 30 cycles, 
each of 94~  for 1 rain, 60~  for 1 min, and 72~  for 1 rain. 
A second amplification  was performed using a 5' primer containing 
an A to T point mutation at position 8847 (primer-4, CCTGCT- 
GTAAGGGAAAGAATG__TGACGAGCT)  and a 3'  primer con- 
taining sequence bases 8966-8941 (primer-2, TGCTTCTAGCCA- 
GGCACAAGCAGCAT). The products from these two reactions 
were purified from a 3% agarose gel (NuSieve GTG; FMC Bio- 
products, Rockland, ME) using a DNA purification system  (Magic 
PCR Preps; Promega  Corp., Madison,  WI). The purified  fragments 
were combined and used as template with primers 1 and 2 in the 
third PCK amplification.  The resulting products were then digested 
with BamHI and XhoI for 3 h at 37~  The digested DNA was 
then gel purified, ligated into BamHI/XhoI-cut, alkaline phos- 
phatase-treated  pNL4-3,  and  used to  transform E.  coli strain 
MC1061. Plasmid DNA was tested for the presence of the desired 
point mutations by screening with sequence-specific  oligonucleo- 
tide probes. The presence of expected sequences in the mutant clones 
Anef and nef/DS was confirmed by DNA sequence analysis (Se- 
quenase 2.0 kit, United States Biochemical  Corp., Cleveland,  OH). 
Plasmid preparations of pNL4-3, pAnef, and pnef/DS were grown 
in large scale and purified by banding on CsC1 gradients. 
Preparations of lnfectious Virus Stocks.  Stocks  of infectious virus 
for clones NL4-3, Anef, and nef/DS were prepared by transfecting 
plasmid DNA into the CEM T lymphoblastoid cell line (27) with 
lipofectin (28). Virus preparations used in this study were derived 
from a single passage of each virus stock through the CEM line. 
A high titer stock of the LAI (LAVB~) strain of HIV-1 was pre- 
pared from infection of CEM cells. Titration of infectivity  was per- 
formed by terminal dilution microassay with the MT-2 cell line 
(29), and the 50% tissue culture infectious  dose (TCIDs0) was cal- 
culated. Titration end points were determined by visible cytopathic 
effects, and confirmed by p24 antigen assay (Abbott Laboratories, 
North Chicago, IL). 
Isolation of CD4 Lymphocytes  from Peripheral  Blood Samples.  Pe- 
ripheral blood was collected  by standard  venipuncture  from healthy, 
HIV-seronegative donors. The mononuclear cell fraction was iso- 
lated by Ficoll-Hypaque density gradient and monocytes were re- 
moved from the cell preparation by ingestion of iron filings (30). 
The resulting lymphocyte-enriched  preparation was processed for 
CD4 lymphocytes  by negative selection with the panning method 
(31). Cell aliquots were incubated at 4~  for 30 min with a mix- 
ture of murine mAbs specific for three antigens: CD8  (OKTS; 
Ortho Diagnostic Systems,  Raritan, NJ), CD16, and CD22 (Leullb 
and Leu14; Becton Dickinson Immunocytometry  Systems,  San Jose, 
CA). The cells were washed with PBS, Dulbecco A and added to 
plastic petri dishes coated with goat antiserum to mouse Ig (IgG 
+  IgM, Kirkegaard and Perry Laboratories, Gaithersburg, MD). 
After a 60-min incubation at 4~  the nonadherent cells were re- 
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complement (Pel-Freeze Clinical Systems,  Brown Deer, WI)  at 
37~  The resulting cell preparations were at least 95% viable by 
trypan blue dye exclusion, and contained 90-98% CD4* lympho- 
cytes as monitored by staining with FITC-conjugated mAb to CD4 
(Leu3a+b, Becton Dickinson) and automated flow cytometry anal- 
ysis on a cytofluorograf  (50 H; Ortho Diagnostic Systems). To en- 
sure that the separation procedure itself did not induce detectable 
cell activation, CD4 cells taken after separation were compared with 
the unfractionated mononuclear cells by direct-staining  flow cytom- 
etry for membrane expression of antigens associated with cell acti- 
vation: CD25, CD71, and DR (mAb anti-IL-2 receptor, antitrans- 
ferrin receptor, anti-MHC  II, respectively;  Becton Dickinson). 
Infection and Induction of Virus Replication from  CD4 Lympho- 
cytes.  For infection,  virus  stocks were diluted in  KPMI  1640 
medium without serum and with 1 #g/ml polybrene to achieve 
equivalent infectivity titers among the specific virus clones used. 
Aliquots of 3-6  x  106 primary quiescent CD4 lymphocytes in 
0.5-1.0 ml were infected with virus during 2-4 h of incubation 
at 37~  at multiplicities of infection (MOI) ranging from 0.5 to 
0.005 TCIDs0 per cell. After incubation, excess virus was removed 
by washing with PBS. Cell recovery was monitored by viable cell 
count with trypan blue dye exclusion.  The infected cells were cul- 
tured in RPMI 1640 medium with 5% human AB serum (Gemini 
Bio-Products, Calabasas,  CA) at 4-5  x  106 cells per 1 ml in 15- 
ml culture tubes (Coming Plastics, Coming, NY). At various times 
after infection, cell viability was determined; cells were distributed 
into round-bottom microtiter plates (Linbro Plastics; Flow Labora- 
tories,  McLean, VA) at 105 cells per 200/~1 medium per well in 
triplicate; and 3/xg/ml PHA (Sigma Chemical Co., St. Louis, MO) 
plus 5 U/ml rlL-2 (DuPont, NEN Research Products, Boston, MA) 
were added to induce cell proliferation and virus replication. 
Unstimulated, infected CD4 cells and uninfected cell controls 
were included for culture. For comparison, virus infection and repli- 
cation in proliferating, prestimulated CD4 cells was determined 
in parallel in each experiment by infecting aliquots of primary CD4 
lymphocytes that had been stimulated 3-4 d earlier with PHA plus 
rlL-2. In selected experiments, virus infection and replication was 
evaluated in a similar manner using the CEM T cell line, grown 
in KPMI medium with  10%  FCS. 
To minimize experimental variation due to individual cell donor 
differences, a given experimental design was repeated two to four 
times using primary cells from different donors. Each figure depicts 
the averaged, combined data obtained from two repeat experiments 
with different cell donors. 
Quantitation of Virus Replication.  Virus production was assessed 
by measuring soluble p24 antigen released into culture superna- 
tams. Samples of 100 #1 were taken from each microculture well 
at the indicated times,  and stored at  -70~  until completion of 
the experiment. Batch assays for p24 antigen quantitation were per- 
formed by the ELISA method (Abbott Laboratories). Supematants 
from uninfected cell cultures were included as controls. 
Each p24 value represents the average of triplicate culture wells. 
Initially, replicate sample aliquots were assayed individually for p24 
content and a mean value was derived mathematically. In subse- 
quent experiments, a different method was used to achieve an equiva- 
lent value; equal volumes from the replicate samples were mixed 
together and the combined sample was  then assayed for average 
p24 content. 
Determination of Cell Proliferation.  To assess levels of cell activa- 
tion and proliferation generated by mitogen stimulation, microcul- 
tures were pulsed with [3H]thymidine (3H-TdR., 2 #Ci/well, Du 
Pont NEN Research Products) for 18-24 h on day 4 after the addi- 
tion of PHA and rlL-2.  Cell cultures were harvested onto glass 
fiber filters with a multiple automated sample harvester (PHD Cam- 
bridge Technology, Watertown, MA) and the amount of isotope 
incorporation was determined by liquid scintillation B-emission. 
Results 
HIV-1  Infection and Replication  in Primary  CD4 Lympho- 
cytes.  In an attempt to reflect more accurately virus-cell in- 
teractions as they occur in vivo, we chose to use an experimental 
culture system of primary T lymphocytes and virus infection 
initiated  in  a  quiescent  cell  state.  CD4  lymphocytes were 
purified with a negative selection technique from the periph- 
eral blood of healthy, HIV-seronegative donors. The LAI strain 
(LAVBgu;  32) and the NL4-3 clone (25) of HIV-1 were used 
to infect resting cells at a MOI of 0.5 TCID50 per cell. At 
various times after infection, PHA mitogen plus recombinant 
IL-2 (rlL-2) were added to microcultures to induce lympho- 
cyte proliferation and productive virus replication.  At each 
time point tested, up to 10 d after infection, mitogen stimu- 
lation induced high levels of HIV-1 replication with 300-700- 
fold increases in soluble p24 antigen production (Fig. 2 A, 
top). Cells infected with either the LAI strain or the NL4-3 
clone achieved peak levels of virus production  7-10 d  after 
each mitogefi induction that equaled or exceeded the levels 
of virus produced during parallel infections of fully prolifer- 
ating CD4 lymphocytes, stimulated 3 d before infection (Fig. 
2 B, top). These results were in general agreement with pre- 
viously reported studies (33, 34) and showed that HIV-1 can 
readily infect quiescent CD4 cells, establish a stable nonproduc- 
tive viral state, and be induced subsequently into productive 
replication through T  cell activation. However, this in vitro 
model represented a unique departure from other experimental 
systems of primary T  cells (15,  33,  34), because it utilized 
isolated CD4 lymphocytes and relatively high virus MOI to 
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Figure  1.  Nefmutations constructed from the NL4-3 clone. Schematic 
representation of the nefgene reading frame of NL4-3 and derived muta- 
tions. The translated sequences  and the resulting AA length of the protein 
product are depicted by open boxes. Base 1 is the translation initiation 
codon which corresponds to sequence  base 8787 for NL4-3 (46). Clone 
nef/DS is a PC/L-derived  mutant containing point mutations that create 
two premature termination codons, 3' of each initiator ATG. Clone Anef 
is a deletion mutant that lacks 185 bases between the intragenic EspI and 
BglII restriction sites, resulting in a premature termination signal at nucleo- 
tide 272 with an expected  product of 29AA. (See  Materials and Methods.) 
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Figure 2.  Isogenic nef deletion clone with reduced capacity to repli- 
cate. (.'t) Primary, quiescent CD4 cells were infected on day 0 with strain 
LAI (.)  or isogenic clones NL4-3 (0) and Anef (A) at MOI  =  0.5 
TCIDs0/cell. PHA and rlL-2 were added on days 0, 3, 6, and 10 after in- 
jection to induce virus replication. Microculture supernatants were tested 
for p24 production on days  4, 7, and 10 after mitogen induction. (B) Virus 
infection and replication was determined in parallel cultures of prolifer- 
ating primary CD4 cells, stimulated 3 d before infection with PHA plus 
rlL-2. Levels  of p24 expressed as nanograms per milliliter on a log10 scale. 
Depicted are the combined, averaged results from two repeated experi- 
ments with different cell donors. 
provide a means to evaluate HIV-1 replication  early in the 
growth cycle and in the absence of potential factors contributed 
by other interacting  cells and cytokines. 
Influence of the nef Gene on Virus Replication.  Earlier studies 
from our laboratory and elsewhere have demonstrated  that 
nefgene transcription  is an early and predominant  event in 
HIV-1 infection of proliferating T cells and monocyte-derived 
macrophages (35-37).  Some of our initial studies with LAI 
infection of quiescent CD4 lymphocytes also indicated that 
nefgene transcription  was the earliest detectable event after 
induction of virus replication (38, and Spina,  C. A., manu- 
script in preparation).  To investigate the impact of nefgene 
expression on HIV-1 infection of primary CD4 lymphocytes, 
a nefdeletion clone was constructed from the pNL4-3 plasmid 
(Fig.  1).  This mutant,  Anef,  contained a 185 base deletion 
within the unique nefreading frame that did not extend 5' 
into env or 3' into the polypurine tract of the LTR. The repli- 
cation competence of the Anefmutant was compared with 
that  of the isogenic NL4-3 parental  clone by infection of 
resting-state CD4 cells (MOI =  0.5) and subsequent mitogen 
stimulation of virus replication, as described above. The Anef 
mutant showed severely reduced capacity to replicate (10-20- 
fold) after mitogen induction of the infected primary cells, 
especially at days 0 and 3 after infection (Fig.  2 A,  bottom). 
When mitogen stimulation was applied at later time points, 
6-10 d after infection, higher peak levels of Anefvirus produc- 
tion were eventually attained.  But,  the growth kinetics of 
the nef-mutated clone still lagged behind that of the parental 
NL4-3 clone, and p24 antigen levels remained approximately 
threefold below those of NL4-3 until 10 d after mitogen in- 
duction.  In contrast with the significant growth disadvan- 
tage seen when T cell activation was initiated after infection, 
the Anef mutant  was capable of replicating  to high  titers, 
rapidly matching p24 antigen levels achieved by NL4-3, when 
virus infection occurred in cultures of prestimulated, prolifer- 
ating CD4 lymphocytes (Fig. 2 B, bottom). Even in this cel- 
lular setting advantageous to virus replication,  the neflmutated 
clone demonstrated a reproducible two to threefold growth 
disadvantage  at  the earliest  time point  after infection. 
The first series of experiments to test the influence of nef 
on virus replication were done with a relatively high virus 
inoculum  of 0.5  TCID50 per  cell.  Additional  experiments 
were done comparing  NL4-3 and Anef replication  kinetics 
at three different MOI, spanning a 100-fold range from 0.005 
to 0.5 TCID50 per cell. Based on the results from earlier ex- 
periments, three time points of 0, 4, and 8 d after infection 
were chosen for PHA mitogen induction  of virus replica- 
tion. The NL4-3 clone replicated to high titers, and reached 
similar peak levels of p24 production  at each MOI and all 
post-infection time points tested (Fig. 3 A). In contrast, the 
replication capacity of the Anef mutant  was dependent on 
high virus dose and the timing of T  cell activation after in- 
fection (Fig.  3 A).  At the lowest MOI of 0.005,  induced 
replication of Anefat 0 and 4 d after infection was 10-100- 
fold less than  the isogenic NL4-3 clone. If infection of the 
resting CD4 cell cultures was allowed to proceed for 8 d be- 
fore the induction ofT cell stimulation, the nef-mutated clone 
was able to attain peak levels of virus production more similar 
to NL4-3, but still showed 3-10-fold reduction in the amounts 
of virus produced during the early cycles of replication.  In 
comparison, infection ofprestimulated CD4 lymphocyte cul- 
tures revealed less of a nefgene influence and minimized the 
effect of virus dose (Fig.  3 B).  Taken  together,  the results 
from these experiments demonstrated a consistently positive 
influence of the NL4-3 nefgene on HIV-1 replication in pri- 
mary CD4 lymphocytes. The effect of nefwas significantly 
greater, and dose related, for virus replication induced from 
infected, resting CD4 cells in comparison with virus replica- 
tion initiated in proliferating cultures of CD4 cells. The data 
indicate that nefgene function may confer a selective growth 
advantage to virus that infects quiescent CD4 cells and is main- 
tained in a latent proviral form for some time before cellular 
activation,  which induces productive viral replication. 
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Figure  3.  Contribution  of virus 
dose on nefef['ects.  (A) Resting  CD4 
cells were  infected  on day  0 with iso- 
genic clones NL4-3 (O) and Anef 
(A) at three different  MOI of 0.5, 
0.05, and 0.005 TCIDs0/cell. On 
days  0, 4, and 8 after  infection,  PHA 
plus rlL-2  were added  and superna- 
tant samples were assayed  for p24 
production  on days  4, 7, 10, and 13 
after mitogen  induction. (B) Virus 
infection  and replication  was also  de- 
termined in proliferating  primary 
CD4 cells, stimulated 4 d earlier 
with PHA plus rlL-2, levels of p24 
are  plotted on  a  log10 scale. 
Depicted are the averaged results 
from  two repeated  experiments  with 
different cell donors. 
Comparison of nef Mutants.  A plasmid clone with point 
mutations in the NL4-3 nefORF was constructed to contain 
two sequential stop codons within the NH2 terminus (Fig. 
1). This mutant, nef/DS, which contained minor base altera- 
tions from the parental genomic sequence,  was used in fur- 
ther experiments to confirm results obtained with the dele- 
tion mutant Anef. As before, virus infection (MOI  =  0.1) 
was initiated in resting CD4 cells, and productive virus repli- 
cation was induced with mitogen stimulation at 0,  4,  and 
8 d after infection. The pattern of replication for the nef/DS 
mutant clone was similar to that of the Anefclone, but showed 
even greater reductions in growth capacity (Fig.  4 A). At 
all time points of mitogen induction, the nef/DS mutant pro- 
duced p24 levels that were 20-500-fold less than those of the 
parental NL4-3 clone. The Anefmutant replicated 5-20-fold 
below the rate of NL4-3 at 0-4 d after infection, and 3-7- 
fold below, at 8 d after infection. The reason for these ob- 
served differences in replication levels between the two nef 
mutant clones is unclear.  Although the Anef construct is 
predicted to express a greatly truncated, but myristoylated, 
fragment of the NEF protein, which might retain some func- 
tion, we have not been able to detect such a protein product 
in these experiments. Analysis of infected cell lysates using 
Western blot with a NEF-specific  rabbit antibody showed 
that the 27-kD product of nefcould be detected after 4-7 d 
of mitogen stimulation in cells infected with NL4-3, but not 
in cells infected with Anefor nef/DS (data not shown). When 
virus replication was compared in proliferating cell cultures 
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of prestimulated CD4 lymphocytes (Fig. 4 B) and the CEM 
T cell line (Fig. 4 C), the nef-mutated clones demonstrated 
better replication rates which were similar to those of NL4- 
3. However, the nef/DS mutant continued to show a relative 
disadvantage in replication in comparison with both NL4-3 
and Anef clones.  The degree of clonal difference seen with 
the CEM cell line (Fig.  4 C) was greatly minimized with 
the addition of several repeat  experiments, and the relative 
growth pattern resembled more closely that seen with pres- 
timulated CD4 lymphocytes (Fig. 4 B). These experiments 
confirmed that nefconfers a positive viral growth advantage 
that is greatly magnified in primary T cells and during events 
of virus transition from a nonproductive state to a fully produc- 
tive state. 
Capacity of lnfectecl CD4 Cells to Respond to T Cell Stimula- 
tion.  Because our experimental model uses T cell stimula- 
tion of primary CD4 cells to induce productive HIV-1 repli- 
cation, the level of virus replication should be directly related 
to the ability of the infected cells to respond to this stimulus 
and proliferate.  The concentration of PHA mitogen used in 
this study was determined by prior titration to induce op- 
timal proliferation in primary cultures of isolated CD4 lym- 
phocytes, but it was not known if similar levels of cell activa- 
tion would be achieved in the infected cell populations. To 
examine whether the observed growth deficiency of the nef- 
mutated clones was associated with an abnormal T cell response 
to mitogen or increased cytopathology, cell proliferation was 
monitored by measuring DNA  synthesis with uptake of A  CD4 Cells Stimulated  Post-Infection 
1000 
100 
E 
~  10 
e- 
01 
OOt 
Post-Infection: 
Post-Stimulation: J 
4  7  10  I  I  I 
4  7  10 
B  CD4 Cells/Pre-Stimulated 
1000 
100 
E 
~  10 
e~ 
0.1 
001 
Post-Infection: J 
y 
8  I  I  I  DAYS 
4  7  10 
C  CEM L.  ine 
0  ,~  "~  10  DAYS 
Figure  4.  Comparison  of  nef 
mutants  containing  deletion  or 
point mutations. (.4) Resting CD4 
cells were  infected  on day 0 with iso- 
genic clones NL4-3 (Q), Anef(A), 
and nef/DS (O)  at MOI  of 0.1 
TCIDs0/cell. On days 0, 4, and 8 
after infection, PHA plus rlL-2  were 
added and supernatant samples  were 
tested for p24 production on the 
days indicated. Virus infection and 
replication were compared in (B) 
proliferating primary CD4  cells, 
stimulated 4 d earlier, and (C) the 
CEM line. Depicted  are the averaged 
results from two repeated experi- 
ments with different cell donors. 
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Figure  5.  Proliferation  capacity  of  infected  primary CD4 cells. Microcul- 
tures of HIV-infected  and uninfected cells, taken from the experiment de- 
scribed in Fig. 4, were assayed for levels of DNA synthesis by [3H]TdR 
uptake. Cells were stimulated with PHA plus rlL-2 on days 0, 4, and 8 
after infection. Cell proliferation was measured on day 4 after mitogen 
stimulation, and expressed as cpm (x  1,000). Each value represents the 
mean of triplicate culture wells. The graph depicts the averaged results 
from two repeated experiments. ([]) Unstimulated CC; (I) stimulated 
CC;  ([~)  stimulated/NL4-3;  ([~)  stimulated/&nef, and ([])  stimu- 
lated/nef-DS. 
[3H]thymidine.  In  the  experiment  described  above,  com- 
paring  replication  of the  Anef and  nef/DS  mutants  with 
NL4-3, the infected cell microcuhures were analyzed for cell 
proliferation after each cycle of mitogen induction on days 
0, 4,  and 8  after infection. 4  d  after the addition of PHA 
and  rlL-2,  the  microwell  cultures  were  pulse  labeled  for 
18-24 h. The peak levels of DNA synthesis in CD4 cells in- 
fected with the nef-mutated clones were similar to those of 
the uninfected cell control at all three time points examined 
(Fig.  5).  In addition,  the induced proliferation of cells in- 
fected with NL4-3 was not different from the levels of prolifer- 
ation seen in cells infected with the mutant  clones, except 
at day 8 after infection. At day 8, cells infected with NL4-3 
exhibited approximately half the level of DNA synthesis de- 
tected in cells infected with either nef mutant or the unin- 
fected cell control. This comparative decrease in cell prolifer- 
ation was probably due to the cytopathology associated with 
high levels of parental NL4-3 replication. Results from these 
experiments demonstrated that the reduced capacity of the 
nefmutant clones to replicate in primary CD4 lymphocytes 
was not associated with an inhibition of induced cell prolifer- 
ation, or with a reduced ability of these infected cells to achieve 
peak levels of DNA  synthesis. 
120  Positive  Influence of nef on HIV-1 Replication Discussion 
We have developed an in vitro cell model to study the regu- 
lation of HIV-1 replication based on our current understanding 
of the natural in vivo life cycle of the CD4 lymphocyte, the 
major target of HIV-1 infection. We have infected primary 
CD4 lymphocytes in a quiescent state,  and induced produc- 
tive virus replication by activation of the T cell response at 
various and extended time periods after infection. Data gener- 
ated by this experimental approach were compared to data 
obtained from parallel infections of fully proliferating CD4 
cells. Our premise has been bolstered by a series of both re- 
cent and prior reports which indicate that HIV-1 infection 
in the majority of CD4 lymphocytes, in both the peripheral 
circulation (17,  18) and in lymph nodes (19,  20), is main- 
tained in a nonproductive, or semiblocked proviral state. Using 
our in vitro cell model to study the influence of the HIV-1 
nefgene on viral replication, we have found that nefconfers 
a positive growth advantage to HIV that is highly significant 
for viral replication induced by T cell activation, but much 
less so for virus infection of proliferating cells. 
The nef gene of NL4-3 was used as the functional ORF 
prototype to derive mutated proviral sequences. Other inves- 
tigators have demonstrated that expression of this particular 
NL4-3 nef gene is associated with disruption of normal T 
cell functions, causing decreased cell membrane expression 
of the CD4  molecule (21),  suppression of IL-2 gene tran- 
scription (23), inhibition of NF-KB induction (24),  and ab- 
normal depletion of thymic T cells in transgenic mice (39). 
For our studies of virus replication, isogenic nefmutants were 
constructed from NL4-3 to contain either a deletion or point 
mutation. By using purified, primary CD4 lymphocytes as 
targets for infection and relatively high virus inoculum, we 
were able to examine early growth cycle events and compare 
kinetics of replication, as well as, peak levels of virus produc- 
tion. The virus clones with nef mutations displayed repro- 
ducible and significant reductions in both growth rate and 
maximal titers achieved. The magnitude of these reductions 
was dependent on initial virus inoculum and the timing of 
T  cell activation. 
We do not understand fully the observed phenomenon of 
relative enhancement of virus replication when mitogen in- 
duction is applied to infected, quiescent CD4 cells after an 
extended time (8 d). This phenomenon is very consistent, 
however, and has been found with several different parental 
clones of HIV-1 and additional, nonisogenic mutants of nef 
(data not shown). We do not believe that it is related to an 
overt change in the resting state of the isolated CD4 cells 
over time in culture. Both uninfected and infected cultures 
of resting cells have been monitored for signs of T cell activa- 
tion over 8-10 d in culture. No changes have been detected 
in basal  levels of DNA  synthesis,  shifts in cell cycle from 
G0/G1 to GffS, or expression of membrane markers of IL-2 
receptor, transferrin receptor, MHC class II, and CD45RO 
(data not shown). Rather than a change in cell state, a subtle 
change in the predominant state of the virus has been ob- 
served. Data from another series of experiments employing 
PCR analysis  suggest that full-length proviral DNA is de- 
tected and accumulates slowly after 5-6 d of infection in pri- 
mary cultures of resting CD4 lymphocytes (40, and Spina, 
C. A., manuscript in preparation). The implications of these 
findings for our study reported here are unclear, but may re- 
late to the stability of the proviral form and/or the compli- 
cated dynamics of induced virus replication in primary CD4 
cells. After mitogen stimulation, two parallel series of events 
occur: the progression of the HIV-1 life cycle to transcrip- 
tion and translation of regulatory genes, and the progressive 
induction of T  cell regulatory factors required to move the 
cell into DNA synthesis and mitosis. The initiation and elon- 
gation of viral RNA transcripts (41, 42), as well as the switch 
from regulatory to structural gene transcription (43-45), is 
highly dependent on interactions between viral regulatory 
proteins and induced cellular factors. It is likely that the pro- 
tein product of nef also interacts directly or indirectly with 
cellular factors,  and this interaction would be dependent on 
the presence and abundance of both nefand cellular products 
during the sequence of events following T  cell activation. 
Our data indicate that nefhas a predominant, selective effect 
on HIV-1 replication that is relevant to the biological set- 
ting of primary T cells undergoing transition from a resting 
to  an activated state.  When virus infection occurs in pre- 
stimulated, highly proliferating cells, the effect of nefis greatly 
diminished. This suggests that the presence and/or abundance 
of putative cellular factors, found in a state of maximal prolifer- 
ation, reduces the requirement for nefin the virus life cycle. 
Other studies, which have shown a modest, positive influence 
of nefon virus replication in cultures of proliferating PBMC 
and some T cell lines, have used low virus inoculum and nef 
genes from primary dinical isolates  (10) and the Eli clone 
(11) expressed in the genetic background of HXB2,  a low 
growth HIV-1 phenotype that contains additional gene defects 
in vpr and vpu (46).  Because it has been shown that the vpu 
gene product also interacts to downregulate CD4 expression 
and  allow  efficient virus  production,  it  has been unclear 
whether the effects of nefon HIV replication in vitro could 
be revealed only in the particular genetic context of defective 
vpu function. Our study has used the high growth virus pheno- 
type of NL4-3, which has ORF for all major genes, and de- 
rived isogenic nef mutants in experiments with a range of 
high to moderate MOI. Our results indeed confirm that nef 
exerts a positive growth influence on HIV-1 replication, but 
also demonstrate a significantly greater impact of nefthat is 
selective for T cell induction of virus replication from a non- 
productive state into a productive cycle. The experimental 
cell model that we describe here provides not only a means 
to study nef function in vitro, but also provides important 
clues to the function of nef in HIV infection in vivo. 
It has been difficult to reconcile the divergent findings for 
the influence of the nefgene between in vitro culture studies 
and the in vivo study of SIV infection of the macaque (1). 
Minimal to no effects have been found for nefin HIV-1 in- 
fection of T cell cultures, whereas nefhas been shown to be 
essential for high rates of virus replication and associated dis- 
ease pathogenesis in the SIV animal model. Our study demon- 
121  Spina et al. strates a positive contribution of neJ to the HIV-1 life cycle 
in primary CD4 cells that is consistent with findings in the 
animal model of SIV infection. We propose that nefconfers 
a significant growth advantage to HIVol in vivo by providing 
a maximal virus burst  from infected CD4 cells  early after 
induction by T cell activation, thus ensuring high virus produc- 
tion from an infected cell before it is recognized and removed 
by immune competent cells. We hypothesize that in the pres- 
ence of a functional immune system, nefis required for the 
rapid spread and seeding of virus in host cells during initial 
infection and for the sustained spread of  virus within the CD4 
lymphocyte population, especially during earlier phases  of 
HIV-1 disease. 
We thank Linda Terry and MaryAnn De1 Fiorentino for expert technical assistance, and Dr. Didier Trono 
for his helpful comments  and encouragement. 
This work was supported by Department of Veterans Affairs Merit Award (C. A. Spina), National Insti- 
tutes of Health grants AI-27670, AI-29164, AI-57578 (D. D.  Richman),  and the Research Center for 
AIDS and HIV Infection of the San Diego Veterans Affairs Medical Center. 
Address correspondence to Dr. C. A. Spina, Department of Pathology (0679), University of California 
San Diego, 9500 Gilman Drive, La  Jolla, CA 92093-0679. J. Kwoh is currently at GenProbe, 9880 Campus 
Point Drive, San Diego, CA 92121. 
Received for publication  28June  1993 and in  revised form  9  September  1993. 
References 
1.  Kestler, H.W.,  D.J. Ringler,  K.  Mori,  D.L.  Panicali, P.K. 
Sehgal, M.D. Daniel, and R.C. Desrosiers. 1991. Importance 
of the nef gene for maintenance of high virus loads and for 
the development of AIDS. Cell. 65:651. 
2.  Delassus, S., R. Cheynier, and S. Wain-Hobson. 1991. Evolu- 
tion of human immunodeficiency virus type 1 nef and long 
terminal repeat sequences over 4 years in vivo and in vitro. J. 
Virol. 65:225. 
3.  Blumberg, B., L.G. Epstein, Y. Saito, D. Chen, L.R.  Sharer, 
and R. Anand.  1992. Human immunodeficiency virus type 
1 nefquasispecies in pathological tissue, j.  Virol. 66:5256. 
4.  Terwilliger, E., J.G. Sodroski, C.A. Rosen, and W.A. Hasel- 
tine. 1986. Effects of mutations within the 3' off  open reading 
frame region  of human  T  cell lymphotropic  virus type III 
(HTLV-III/LAV) on replication and cytopathogenicity.J. Virol. 
60:754. 
5.  Luciw, P.A., C. Cheng-Mayer, andJ.A. Levy.  1987. Mutational 
analysis of the human immunodeficiency virus: the orf-B re- 
gion down-regulates  virus replication. Proc. Natl. Acad. Sci. 
USA.  84:1434. 
6.  Ahmad,  N., and S. Venkatesan. 1988. Nefprotein of HIV-1 
is a transcriptional repressor of HIV-1 LTR. Science (Wash. DC). 
241:1481. 
7.  Niederman, T.M.J., B.J. Thielan, and L. Ratner. 1989. Human 
immunodeficiency virus type 1 negative factor is a transcrip- 
tional silencer. Proc. Natl. Acad. Sci. USA.  86:1128. 
8.  Kim, S., K. Ikeuchi, R. Byrn, J. Groopman,  and D. Balti- 
more. 1989. Lack of a negative influence on viral growth by 
the nef gene of human immunodeficiency virus type 1. Proa 
Natl. Acad,  Sci. USA.  86:9544. 
9.  Hammes, S.R., E.P. Dixon, M.H. Malim, B.R. Cullen, and 
W.C. Greene. 1989. Nefprotein of human immunodeficiency 
virus type 1: evidence against its role as a transcriptional in- 
hibitor. Proc. Natl.  Acad. Sci. USA.  86:9549. 
10.  de Ronde, A., B. Klaver,  W. Keulen, L. Smit, andJ. Goudsmit. 
1992. Natural nefaccelerates  virus replication  in primary human 
lymphocytes. Virology. 188:391. 
11.  Terwilliger, E.F., E. Langhoff, D. Gabuzda, E. Zazopoulos, 
and W.A.  Haseltine. 1991. Allelic variation in the effects of 
the nefgene on replication of human immunodeficiency virus 
type 1. Proc. Natl. Acad. Sci. USA.  88:10971. 
12.  Rather, L., B. Starcich, S.F. Josephs, B.H. Hahn, E.P. Reddy, 
K.J. Livak, S.R. Petteway,  M.L. Pearson, W.A. Haseltine, S.K. 
Arya, and F. Wong-Staal. 1985. Polymorphism of the 3' open 
reading frame of the virus associated with the acquired im- 
mune deficiency  syndrome, human T-lymphotrophic  virus type 
III. Nucleic Acids Res. 13:8219. 
13.  Fisher, A.G., L.  Ratner,  H. Mitsuya, L.M.  Marselle, M.E. 
Harper, S. Broder, R.C. Gallo, and F. Wong-Staal. 1986. In- 
fectious mutants  of HTLV-III with changes in the 3' region 
and markedly reduced cytopathic effects. Science (Wash. DC). 
233:655. 
14.  McDougal, J.S., A. Mawle, S.P. Cort, J.K.A. Nicholson, G.D. 
Cross, J.A. Scheppler-Campbell, D. Hicks, andJ. Sligh. 1985. 
Cellular tropism of the human retrovirus HTLV-III/LAV I. 
Role of T cell activation and expression of the T4 antigen. 
J.  Immunol.  135:3151. 
15.  Zagury, D., J. Bernard, R. Leonard, R. Cheynier, M. Feldman, 
P.S. Satin, and R.C. Gallo. 1986. Long-term cultures of HTLV 
III infected T cells: A model of cytopathology of T cell deple- 
tion in AIDS. Science (Wash. DC).  231:850. 
16.  Corner, T., J.M. Williams, L. Christensen, H.M. Shapiro, T.B. 
Strom,  and J.L. Strominger.  1983. Simultaneous flow cyto- 
metric analysis of human T cell activation antigen expression 
and DNA content. J.  Exp.  Med. 157:461. 
17.  Bukrinsky,  M.I.,  T.L.  Stanwick,  M.P. Dempsey, and  M. 
Stevenson. 1991. Quiescent T lymphocytes  as an inducible  virus 
reservoir in HIV-1 infection. Science (Wash. DC).  254:423. 
18.  Seshamma, T., O. Bagasra, D. Trono, D. Baltimore, and R.J. 
Pomerantz. 1992. Blocked early-stage  latency in the peripheral 
122  Positive  Influence of nef on HIV-1 Replication blood cells of certain individuals infected with human  im- 
munodeficiency virus  type  1.  Proa Natl.  Acad. Sci. USA. 
89:10663. 
19.  Embretson, J., M. Zupancic, J.L. Kibas, A. Burke, P. Racz, 
K. Tenner-Racz, and A.T. Haase. 1993. Massive covert infec- 
tion of helper T lymphocytes & macrophages by HIV during 
the incubation  period of AIDS. Nature (Lond.). 362:359. 
20.  Pantaleo, G., C. Graziosi, J.F. Demarest, L. Butini, M. Mon- 
troni, C.H. Fox, J.M. Orenstein, D.P. Kotler, and A.S. Fauci. 
1993. HIV infection is active  and progressive  in lymphoid tissue 
during  the clinical latent  stage of disease. Nature  (Lond.). 
362:355. 
21.  Guy, B., M.P. Kieny, Y, Riviere, C. Le Peuch, K. Dott, M. 
Girard, L. Montagnier, and J.P. Lecocq. 1987. HIV F/Y orf 
encodes a phosphorylated GTP-binding protein resembling an 
oncogene product.  Nature (Lond.). 330:266. 
22.  Garcia, V., and A.D.  Miller. 1991. Serine phosphorylation- 
independent down-regulation of cell-surface CD4 by nef. Na- 
ture (Lond.). 350:508. 
23.  Luria, S., I. Chambers, and P. Berg. 1991. Expression of the 
type 1 human immunodeficiency virus nefprotein in T cells 
prevents antigen receptor-mediated induction of interleukin-2 
mRNA. Proc. Natl.  Acad. Sci. USA.  88:5326. 
24.  Niederman, T.M.J., J.V. Garcia, W.R. Hastings, S. Luria, and 
L. Ratner.  1992. Human immunodeficiency virus type 1 nef 
protein inhibits NF-~B induction in human T cells.  J.  Virol. 
66:6213. 
25.  Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, 
A. Rabson, and M.A.  Martin.  1986. Production of acquired 
immunodeficiency syndrome-associated retrovirus in human 
and nonhuman cells transfected with an infectious molecular 
clone. J.  ViroL 59:284. 
26.  Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. 
Pease. 1989. Site-directed mutagenesis by overlap extension 
using the polymerase chain reaction. Gene. 77:51. 
27.  Folks, T.M., S. Benn, A. Rabson, T. Theodore, M.D. Hoggan, 
M. Martin,  M. Lightfoote,  and K. Sell. 1985. Characteriza- 
tion of a continuous  T-cell line susceptible to the cytopathic 
effects of the AIDS retrovirus. Proc. Natl.  Acad. Sci. USA. 
82:4531. 
28.  Feigner, P.L., T.R. Gader, M. Holm, R. Roman, H.W. Chan, 
M. Wenz, J.P. Northrop, G.M.R.ingold,  and M. Danielson. 
1987. Lipofectin:  a  highly  efficient, lipid-mediated  DNA- 
translation procedure. Proc. Natl.  Acad. Sci. USA.  84:7413. 
29.  Haertle, T., C.J. Carrera, J.S. McDougal, L.C. Sowers, D.D. 
Richman, and D.A. Carson. 1988. Metabolism and anti-HIV 
activity of 2'-halo-2',Y-dideoxyadenosine derivatives.  J. BioL 
Chem.  263:5870. 
30.  Spina, C.A., D. Smith, E. Korn, J.L. Fahey, and H.J. Grossman. 
1981. Altered  cellular immune  functions  in  patients  with 
Down's  syndrome. Am. J. Dis. Child. 135:251. 
31.  Wysocki, L.J., and V.L. Sato. 1978. Panning for lymphocytes: 
method for cell selection. Proc. Natl. Acad. Sci. USA. 75:2844. 
32.  Montagnier, L. 1985. Lymphadenopathy-associated  virus: from 
molecular biology to pathogenicity. Ann. Intern. Med. 103:689. 
33.  Stevenson, M.,  T.L.  Stanwick,  M.P. Dempsey, and  C.A. 
Lamonica. 1990. HIV-1 replication is controlled at the level 
of T cell activation and proviral integration. EMBO (Eur. Mol. 
Biol. Organ.)  J.  9:1551. 
34.  Zack,  J.A., S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip, 
and I.S.Y. Chen. 1990. HIV-1 entry into quiescent primary lym- 
phocytes: molecular analysis reveals a labile, latent viral struc- 
ture. Cell. 61:213. 
35.  Guatelli, J.C., T.R. Gingeras, and D.D. Richman.  1990. Al- 
ternative  splice acceptor  utilization  during  human  im- 
munodeficiency  virus type I infection of cultured cells.J. Virol. 
64:4093. 
36.  Robert-Guroff, M., M. Popovic,  S. Gartner, P. Markham, K.C. 
Gallo, and M.S. Reitz. 1990. Structure and expression of tat-, 
rev- and nef-specific transcripts of human  immunodeficiency 
virus type I in infected lymphocytes and macrophages.J. Virol. 
64:3391. 
37.  Munis,  J.R., R.S. Kornbluth, J.C. Guatelli, and D.D. Richman. 
1992. Ordered appearance  of  HIV-1 nucleic acids following high 
multiplicity infection of macrophages.J.  Gen. Virol. 73:1899. 
38.  Spina, C.A., J.C. Guatelli, and D.D. Richman. 1990. HIV repli- 
cation  in primary CD4 lymphocyte cultures:  induction  of 
regulatory  and structural  gene expression by activation and 
DNA synthesis. J.  Cell. Biochem. Suppl. 14D, 128. (Abstr.) 
39.  Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T 
cell activation and development in transgenic mice expressing 
the HIV-1 nefgene. EMBO (Eur. Mol. Biol. Organ.)J. 12:703. 
40.  Spina, C.A.,  T.J. Kwoh, and D.D. Richman.  1992. Reverse 
transcription and establishment of a replication-competent  form 
of HIV-1 DNA in quiescent primary CD4 lymphocytes.J. Cell. 
Biochem. Suppl. 16E, 42.  (Abstr.) 
41.  Feinberg, M.B., R.F. Jarrett, A. Aldovini, R.C. Gallo, and 
F. Wong-Staal. 1986. HTLV-III expression and production in- 
volve complex regulation at the levels of splicing and transla- 
tion of viral RNA.  Cell. 46:807. 
42.  Culen, B.R.,  and W.C. Greene. 1989. Regulatory pathways 
governing HIV-1 replication. Cell. 58:423. 
43.  Felber, B.K.,  M.  Hadzopoulou-Cladaras,  C.  Cladaras,  T. 
Copeland, and G.N. Pavlakis. 1989. Rev protein of human im- 
munodeficiency virus type I affects the stability and transport 
of the viral mRNA. Proc. Natl. Acad. Sci. USA.  86:1495. 
44.  Kim, S.-Y., R. Byrn, J. Groopman, and D. Baltimore. 1989. 
Temporal aspects of DNA and RNA synthesis during human 
immunodeficiency  virus infection: evidence  for differential  gene 
expression. J.  Virol. 63:3708. 
45.  Pavlakis, G.N., and B.K. Felber. 1990. Regulation of expres- 
sion of human  immunodeficiency virus. New Biol. 2:20. 
46.  Myers, G., J.A. Berzofsky, B. Korber, R.F. Smith, and G.N. 
Pavlakis, editors. 1992. Human Retroviruses and AIDS. Sec. 
III. Los Alamos National  Laboratory, New Mexico. 
123  Spina et al. 